We conducted a survival analysis of the IL‐33+ Venous‐1 marker genes, and the results revealed that high expression of IL‐33, MADCAM1, SELP/CD62P, and SELE/ELAM1 in GC was correlated with poor patient prognosis (Figures 4K and S8B). This evidence concerns the gene SELE and gastric cancer.